Alzheimer Disease

The Pharmacy Times® Alzheimer Disease Resource Center is a comprehensive resource for clinical news and expert insights on treatments for Alzheimer disease.

Latest News

Novel Treatments Could Turn the Tide for Alzheimer Disease
Novel Treatments Could Turn the Tide for Alzheimer Disease

June 13th 2024

Anti-amyloid antibody administration decreased plaque volume in clinical trials of patients with early AD, indicating that passive immunotherapies could be a promising treatment for the disease.

MRI scan showing dementia-related deterioration -- Image credit: Atthapon | stock.adobe.com
Neurobiologically Informed DMN Effective Connectivity Model Accurately Predicts Individual Development of Dementia

June 12th 2024

Medical - Image credit: BillionPhotos.com | stock.adobe.com
FDA Panel Endorses Donanemab to Treat Early-Stage Alzheimer Disease

June 11th 2024

Ozempic semaglutide injection -- Image credit: mbruxelle | stock.adobe.com
Five Unexpected New Uses for GLP-1 Receptor Agonists

May 23rd 2024

Alzheimer's disease MRI -- Image credit: DedMityay | stock.adobe.com
Pharmacists’ Impact on Care for Patients With Alzheimer Disease

May 21st 2024

More News

Alzheimer Centers in North Carolina, Texas Join NIH Network

Alzheimer Centers in North Carolina, Texas Join NIH Network

Ashley Gallagher, Associate Editor
September 13th 2021

The National Institutes of Health grants each entity $14.8 million in funding over the course of 5 years to conduct research into the progressive disease.

Read More

Aducanumab May Indicate Erosion of Drug Approval Standards

Aducanumab May Indicate Erosion of Drug Approval Standards

Curtis E. Haas , PharmD, FCCP
September 1st 2021

The FDA's green light for the Alzheimer medication is worrisome, as clinical trials proved inconclusive.

Read More

Ongoing Developments and Barriers for Treatment of Alzheimer Disease

Ongoing Developments and Barriers for Treatment of Alzheimer Disease

Elise Palatine
August 23rd 2021

It is the responsibility of the pharmacist to remain informed of all existing and new drugs for the treatment of Alzheimer disease, especially because novel and investigational drugs may target the pathophysiology of the disease.

Read More

<1234
© 2024 MJH Life Sciences

All rights reserved.